Literature DB >> 24042023

Drug dissolution: significance of physicochemical properties and physiological conditions.

Sunil S Jambhekar1, Philip J Breen.   

Abstract

Oral bioavailability of a drug is determined by a number of properties, including drug dissolution rate, solubility, intestinal permeability and pre-systemic metabolism. Frequently, the rate limiting step in drug absorption from the gastrointestinal tract is drug release and drug dissolution from the dosage form. Therapeutic agents with aqueous solubilities less than 100μg/ml often present dissolution limitations to absorption. Physicochemical, formulation-related and physiological factors can all influence drug dissolution. In this review, the authors will discuss the important physicochemical properties of a drug and physiological conditions in the gastrointestinal tract that play an important part in drug dissolution and absorption processes and, consequently, the bioavailability of a drug.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24042023     DOI: 10.1016/j.drudis.2013.08.013

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  12 in total

Review 1.  Novel thyroxine formulations: a further step toward precision medicine.

Authors:  Camilla Virili; Pierpaolo Trimboli; Marco Centanni
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

Review 2.  Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models.

Authors:  Louis Lin; Harvey Wong
Journal:  Pharmaceutics       Date:  2017-09-26       Impact factor: 6.321

3.  Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies.

Authors:  Raymond Fong; Megan E Cavet; Heleen H DeCory; Jason L Vittitow
Journal:  Clin Ophthalmol       Date:  2019-08-01

Review 4.  The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability.

Authors:  Jannes van der Merwe; Jan Steenekamp; Dewald Steyn; Josias Hamman
Journal:  Pharmaceutics       Date:  2020-04-25       Impact factor: 6.321

5.  Impact of water hardness on oxytetracycline oral bioavailability in fed and fasted piglets.

Authors:  Julieta M Decundo; Susana N Diéguez; Guadalupe Martínez; Agustina Romanelli; María B Fernández Paggi; Denisa S Pérez Gaudio; Fabián A Amanto; Alejandro L Soraci
Journal:  Vet Med Sci       Date:  2019-07-08

Review 6.  Levothyroxine Therapy in Gastric Malabsorptive Disorders.

Authors:  Camilla Virili; Nunzia Brusca; Silvia Capriello; Marco Centanni
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-28       Impact factor: 5.555

7.  Rational formulation engineering of fraxinellone utilizing 6-O-α-D-maltosyl-β-cyclodextrin for enhanced oral bioavailability and hepatic fibrosis therapy.

Authors:  Jianbo Li; Tiange Feng; Weijing Yang; Yaru Xu; Shuaishuai Wang; Huijie Cai; Zhilei Liu; Hong Qiang; Jinjie Zhang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

8.  Characterizing the Physicochemical Properties of Two Weakly Basic Drugs and the Precipitates Obtained from Biorelevant Media.

Authors:  Miao Zhang; Bin Wu; Shudong Zhang; Lin Wang; Qin Hu; Dongyang Liu; Xijing Chen
Journal:  Pharmaceutics       Date:  2022-01-29       Impact factor: 6.321

Review 9.  Intestinal Absorption Study: Challenges and Absorption Enhancement Strategies in Improving Oral Drug Delivery.

Authors:  Maisarah Azman; Akmal H Sabri; Qonita Kurnia Anjani; Mohd Faiz Mustaffa; Khuriah Abdul Hamid
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-08

10.  Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets.

Authors:  Sileshi Belew; Sultan Suleman; Markos Duguma; Henok Teshome; Evelien Wynendaele; Luc Duchateau; Bart De Spiegeleer
Journal:  Malar J       Date:  2020-04-07       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.